October 17, 2017 4:55 PM ET

Pharmaceuticals

Company Overview of Corcept Therapeutics Incorporated

Executive Profile

Robert S. Fishman M.D., ‚ F.C.C.P.

Chief Medical Officer, Corcept Therapeutics Incorporated
AgeTotal Calculated CompensationThis person is connected to 0 Board Member in 0 organization across 4 different industries.

55$685,430
As of Fiscal Year 2016

Background

Dr. Robert S. Fishman, also known as Bob, M.D., ‚ F.C.C.P., has been the Chief Medical Officer of Corcept Therapeutics Incorporated since September 28, 2015. Dr. Fishman served as Senior Vice President of Clinical Development at InterMune, Inc. since May 2012, where he was responsible for InterMune’s Clinical Science, Clinical Operations and Biometrics activities. Prior to his tenure at InterMune, Dr. Fishman served as Vice President of Clinical Development of Alexza ...

Corporate Headquarters

149 Commonwealth Drive
Menlo Park, California 94025

United States

Phone: 650-327-3270
Fax: 650-327-3218

Board Members Memberships

There is no Board Members Memberships data available.

Education

BA
Harvard University
MD
Stanford University School of Medicine

Other Affiliations

Annual Compensation

Salary$411,363
Bonus$40,000
Total Annual Compensation$451,363

Stocks Options

Exercisable Options$153,645
Exercisable Options Value$568,461
Unexercisable Options$371,355
Unexercisable Options Value$1,363,289
Total Value of Options$1,931,750
Total Number of Options$525,000

Total Compensation

Total Annual Cash Compensation$451,363
Total Short Term Compensation$451,363
Total Calculated Compensation$685,430
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Joseph Jimenez Jr., MBAChief Executive Officer
Novartis AG
$4.9M
Compensation as of Fiscal Year 2016.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Corcept Therapeutics Incorporated, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.